• Je něco špatně v tomto záznamu ?

First Dimension Trap-and-Elute Combined with Second Dimension Reversed-Phase Liquid Chromatography Separation Using a Two-Dimensional-Liquid Chromatography-Tandem Mass Spectrometry System for Sensitive Quantification of Human Insulin and Six Insulin Analogs in Plasma: Improved Chromatographic Resolution and Stability Testing

P. Sistik, R. Urinovska, K. Handlosova, P. Handlos, K. Andelova, J. Jurica, D. Stejskal

. 2025 ; 48 (2) : e70092. [pub] -

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009993

Grantová podpora
29-RVO-FNOs/2020 Ministry of Health, Czech Republic-Conceptual Development of Research Organization

Multidimensional chromatography coupled to tandem mass spectrometry (MS/MS), including simple sample preparation with protein precipitation, anion conversion with ammonium hydroxide, and solid-phase extraction using mixed-mode anion exchange in a 96-well plate format, has been validated for rapid simultaneous analysis of human insulin and its six analogs (lispro, glulisine, glargine, degludec, detemir, and aspart) in human plasma. This method is critical for clinical diagnostics, forensic investigations, and anti-doping efforts due to the widespread use of these substances. In the present study, improved chromatographic resolution was achieved using a first-dimension trap-and-elute configuration with an XBridge C18 (2.1 × 20 mm, 3.5 μm) trap column combined with second dimension separation on a Cortecs Ultra-High-Performance Liquid Chromatography (UHPLC) C18+ (2.1 × 100 mm, 1.6 μm) analytical column implemented within a two-dimensional-LC-MS/MS system. The total chromatographic run time was 11 min. This setup increases both the resolution and sensitivity of the method. A mobile phase consisting of 0.8% formic acid (FA) in water and 0.7% FA in acetonitrile was used for gradient elution. Bovine insulin was used as the internal standard. MS detection was performed in positive electrospray ionization mode, and the ion suppression due to matrix effects was evaluated. Validation criteria included linearity, precision, accuracy, recovery, lower limit of quantitation, matrix effect, and stability tests with and without protease inhibitor cocktail under different conditions (short-term stability, long-term stability, and freeze-thaw stability). The concentration range for all insulins was 50-15 000 pg/mL, with limits of quantification below the therapeutic reference range for all analytes. Intra-run precision ranged from 1.1% to 5.7%, inter-run precision from 0.7% to 5.9%, and overall recovery from 96.9% to 114.3%. The validated method has been implemented successfully by the Department of Forensic Medicine at our hospital for the investigation of unexplained deaths.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009993
003      
CZ-PrNML
005      
20250429134914.0
007      
ta
008      
250415s2025 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jssc.70092 $2 doi
035    __
$a (PubMed)39930590
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Sistik, Pavel $u Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
245    10
$a First Dimension Trap-and-Elute Combined with Second Dimension Reversed-Phase Liquid Chromatography Separation Using a Two-Dimensional-Liquid Chromatography-Tandem Mass Spectrometry System for Sensitive Quantification of Human Insulin and Six Insulin Analogs in Plasma: Improved Chromatographic Resolution and Stability Testing / $c P. Sistik, R. Urinovska, K. Handlosova, P. Handlos, K. Andelova, J. Jurica, D. Stejskal
520    9_
$a Multidimensional chromatography coupled to tandem mass spectrometry (MS/MS), including simple sample preparation with protein precipitation, anion conversion with ammonium hydroxide, and solid-phase extraction using mixed-mode anion exchange in a 96-well plate format, has been validated for rapid simultaneous analysis of human insulin and its six analogs (lispro, glulisine, glargine, degludec, detemir, and aspart) in human plasma. This method is critical for clinical diagnostics, forensic investigations, and anti-doping efforts due to the widespread use of these substances. In the present study, improved chromatographic resolution was achieved using a first-dimension trap-and-elute configuration with an XBridge C18 (2.1 × 20 mm, 3.5 μm) trap column combined with second dimension separation on a Cortecs Ultra-High-Performance Liquid Chromatography (UHPLC) C18+ (2.1 × 100 mm, 1.6 μm) analytical column implemented within a two-dimensional-LC-MS/MS system. The total chromatographic run time was 11 min. This setup increases both the resolution and sensitivity of the method. A mobile phase consisting of 0.8% formic acid (FA) in water and 0.7% FA in acetonitrile was used for gradient elution. Bovine insulin was used as the internal standard. MS detection was performed in positive electrospray ionization mode, and the ion suppression due to matrix effects was evaluated. Validation criteria included linearity, precision, accuracy, recovery, lower limit of quantitation, matrix effect, and stability tests with and without protease inhibitor cocktail under different conditions (short-term stability, long-term stability, and freeze-thaw stability). The concentration range for all insulins was 50-15 000 pg/mL, with limits of quantification below the therapeutic reference range for all analytes. Intra-run precision ranged from 1.1% to 5.7%, inter-run precision from 0.7% to 5.9%, and overall recovery from 96.9% to 114.3%. The validated method has been implemented successfully by the Department of Forensic Medicine at our hospital for the investigation of unexplained deaths.
650    _2
$a lidé $7 D006801
650    12
$a tandemová hmotnostní spektrometrie $x metody $7 D053719
650    12
$a chromatografie s reverzní fází $7 D056148
650    12
$a inzulin $x krev $x analogy a deriváty $7 D007328
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a extrakce na pevné fázi $7 D052616
655    _2
$a časopisecké články $7 D016428
700    1_
$a Urinovska, Romana $u Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000239818841
700    1_
$a Handlosova, Klara $u Department of Forensic Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Forensic Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Handlos, Petr $u Department of Forensic Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Forensic Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Andelova, Katerina $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Jurica, Jan $u Department of Pharmacology, Faculty of Medicine and Department of Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Brno, Czech Republic
700    1_
$a Stejskal, David $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Department of Pharmacology, Faculty of Medicine and Department of Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Brno, Czech Republic
773    0_
$w MED00006463 $t Journal of separation science $x 1615-9314 $g Roč. 48, č. 2 (2025), s. e70092
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39930590 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134910 $b ABA008
999    __
$a ok $b bmc $g 2311391 $s 1247074
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 48 $c 2 $d e70092 $e - $i 1615-9314 $m Journal of separation science $n J Sep Sci $x MED00006463
GRA    __
$a 29-RVO-FNOs/2020 $p Ministry of Health, Czech Republic-Conceptual Development of Research Organization
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace